Envoy Medical COCH Issuance of common stock in connection with the Spin-Off and reclassification of net parent investment
Issuance of common stock in connection with the Spin-Off and reclassification of net parent investment at other companies
Other financials
Where this comes from
Reported directly by Envoy Medical in its filing.
Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueNewIssues.
The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Envoy Medical's issuance of common stock in connection with the spin-off and reclassification of net parent investment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Envoy Medical's issuance of common stock in connection with the spin-off and reclassification of net parent investment?
- Envoy Medical (COCH) reported issuance of common stock in connection with the spin-off and reclassification of net parent investment of $27.78M in Q1 2026.
- How has Envoy Medical's issuance of common stock in connection with the spin-off and reclassification of net parent investment changed year-over-year?
- Envoy Medical's issuance of common stock in connection with the spin-off and reclassification of net parent investment increased by 11112700.0% year-over-year, from $250 to $27.78M.
- What does issuance of common stock in connection with the spin-off and reclassification of net parent investment mean?
- Represents the total monetary value of new common stock issued during the reporting period, excluding shares issued for specific services or existing debt conversions. This metric reflects the company's ability to raise primary equity capital from public or private markets to fund operations or growth initiatives.